We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+12.97%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$19B
AUM Growth
+$2.74B
(+17%)
Cap. Flow
+$987M
Cap. Flow
% of AUM
5.19%
Top 10 Holdings %
Top 10 Hldgs %
14.62%
Holding
1,391
New
303
Increased
335
Reduced
266
Closed
474
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$278M |
| 2 |
Fidelity National Information Services
FIS
|
+$161M |
| 3 |
Salesforce
CRM
|
+$160M |
| 4 |
Bread Financial
BFH
|
+$143M |
| 5 |
IQVIA
IQV
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Global Payments
GPN
|
+$247M |
| 2 |
Advanced Micro Devices
AMD
|
+$229M |
| 3 |
ServiceNow
NOW
|
+$213M |
| 4 |
MGM Resorts International
MGM
|
+$150M |
| 5 |
PepsiCo
PEP
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.66% |
| 2 | Consumer Discretionary | 15% |
| 3 | Healthcare | 14.87% |
| 4 | Financials | 11.37% |
| 5 | Industrials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRVL
476
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $5.8M | 0.03% |
+366,324
| New | +$4.67M |
|
477
RPM International
RPM
$13.7B
| $5.79M | 0.03% |
75,441
-5,359
| -7% | -$389K |
|
478
JetBlue
JBLU
$2.28B
| $5.79M | 0.03% |
+309,155
| New | +$5.74M |
|
479
Insmed
INSM
$21.4B
| $5.75M | 0.03% |
240,835
-471,654
| -66% | -$9.59M |
|
480
Pentair
PNR
$10.4B
| $5.75M | 0.03% |
125,262
+100,062
| +397% | +$4.23M |
|
|
CALA
481
DELISTED
Calithera Biosciences, Inc
CALA
| $5.74M | 0.03% |
50,299
-9,701
| -16% | -$730K |
|
|
CNH
482
CNH Industrial
CNH
$12.7B
| $5.7M | 0.03% |
+594,837
| New | +$5.59M |
|
|
TCDA
483
DELISTED
Tricida, Inc. Common Stock
TCDA
| $5.68M | 0.03% |
150,633
-131,091
| -47% | -$4.89M |
|
484
Dover
DOV
$27.6B
| $5.64M | 0.03% |
48,908
-64,467
| -57% | -$6.91M |
|
485
Abeona Therapeutics
ABEO
$366M
| $5.56M | 0.03% |
+68,000
| New | +$4.8M |
|
|
DNKN
486
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $5.51M | 0.03% |
72,984
+11,053
| +18% | +$835K |
|
|
ALBO
487
DELISTED
Albireo Pharma Inc
ALBO
| $5.39M | 0.03% |
212,030
+124,124
| +141% | +$2.48M |
|
488
Range Resources
RRC
$9.38B
| $5.35M | 0.03% |
+1,103,300
| New | +$4.45M |
|
489
Relmada Therapeutics
RLMD
$557M
| $5.34M | 0.03% |
+136,900
| New | +$4.16M |
|
490
Adient
ADNT
$1.65B
| $5.32M | 0.03% |
250,270
+172,070
| +220% | +$3.82M |
|
491
Arbutus Biopharma
ABUS
$857M
| $5.27M | 0.03% |
+1,897,284
| New | +$3.07M |
|
492
Kosmos Energy
KOS
$1.6B
| $5.27M | 0.03% |
924,323
-3,736,263
| -80% | -$22.5M |
|
493
Marriott International
MAR
$98.3B
| $5.19M | 0.03% |
34,292
-5,282
| -13% | -$708K |
|
|
VER
494
DELISTED
VEREIT, Inc.
VER
| $5.15M | 0.03% |
111,527
+94,127
| +541% | +$4.51M |
|
495
Prothena Corp
PRTA
$425M
| $5.1M | 0.03% |
+322,300
| New | +$3.46M |
|
|
AKRO
496
DELISTED
Akero Therapeutics
AKRO
| $5.02M | 0.03% |
226,300
+119,600
| +112% | +$2.47M |
|
497
Ultragenyx Pharmaceutical
RARE
$2.45B
| $5.02M | 0.03% |
117,496
+61,680
| +111% | +$2.54M |
|
|
VIVO
498
DELISTED
Meridian Bioscience Inc
VIVO
| $5.01M | 0.03% |
+513,070
| New | +$4.82M |
|
499
KBR
KBR
$4.62B
| $4.99M | 0.03% |
163,700
-384,557
| -70% | -$10.8M |
|
500
XPO
XPO
$23.5B
| $4.98M | 0.03% |
+180,591
| New | +$4.96M |
|
Similar funds
CBU
BC
Point72 Asset Management's Q4 2019 Portfolio in Review
As of Q4 2019, Point72 Asset Management held 1,391 positions worth $19B, up 17% from $16.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Point72 Asset Management deployed $987M of net new capital in Q4 2019, opening 303 new positions and adding to 335 existing holdings. Its largest new stake was IQVIA: 940,619 shares worth $145M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Global Payments, an estimated $247M trimmed.
- Point72 Asset Management's largest Q4 2019 buy was IQVIA: 940,619 shares worth $145M.
- Point72 Asset Management added most to PayPal in Q4 2019, an estimated $278M increase.
- Point72 Asset Management's biggest Q4 2019 reduction was Global Payments, cutting an estimated $247M.
- Point72 Asset Management fully exited ServiceNow in Q4 2019, selling an estimated $213M.
- Point72 Asset Management's ten largest holdings make up 15% of its $19B portfolio in Q4 2019.
- Point72 Asset Management opened 303 new positions and closed 474 in Q4 2019.
- Point72 Asset Management's portfolio value rose 17% quarter-over-quarter to $19B.
Based on Point72 Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.